Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen - Resultat

Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Frederik N Engsig
Gerstoft, Jan
Kronborg, Gitte
Carsten Schade Larsen
Gitte Pedersen
Anne M Audelin
Louise B Jørgensen
Obel, Niels
Louise B Jørgensen

Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.

Originalsprog	Engelsk
Tidsskrift	Clinical Epidemiology
Vol/bind	2
Sider (fra-til)	145-51
Antal sider	7
Status	Udgivet - 1 jan. 2010

ID: 34052160